共 13 条
[1]
Taribavirin for the treatment of chronic hepatitis C
[J].
EXPERT OPINION ON PHARMACOTHERAPY,
2008, 9 (18)
:3243-3249
Kearney, Keith R.
;
Thornton, James J.
;
Navarro, Victor J.
.
[2]
Thiazolides: a new class of drugs for the treatment of chronic hepatitis B and C[J] . Rossignol, Jean-Fran?§?§Ois,Keeffe, Emmet B.Future Microbiology . 2008 (5)
[3]
Silibinin Is a Potent Antiviral Agent in Patients With Chronic Hepatitis C Not Responding to Pegylated Interferon/Ribavirin Therapy
[J].
GASTROENTEROLOGY,
2008, 135 (05)
:1561-1567
Ferenci, Peter
;
Scherzer, Thomas-Matthias
;
Kerschner, Heidrun
;
Rutter, Karoline
;
Beinhardt, Sandra
;
Hofer, Harald
;
Schoeniger-Hekele, Maximilian
;
Holzmann, Heidemarie
;
Steindl-Munda, Petra
.
[4]
Review on Medusa＜sup＞?＜/sup＞:a polymer-based sustained release technology for protein and peptide drugs[J] . Chan,Meyrueix,Kravtzoff,Nicolas,Lundstrom.Expert Opinion on Drug Delivery . 2007 (4)
[5]
SCH 503034, a Novel Hepatitis C Virus Protease Inhibitor, Plus Pegylated Interferon α-2b for Genotype 1 Nonresponders[J] . Christoph Sarrazin,Regine Rouzier,Frank Wagner,Nicole Forestier,Dominique Larrey,Samir K. Gupta,Musaddeq Hussain,Amrik Shah,David Cutler,Jenny Zhang,Stefan Zeuzem.Gastroenterology . 2007 (4)
[6]
Virological response and safety outcomes in therapy–na?ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: A randomized, phase 2 study[J] . Robert G. Gish,Sanjeev Arora,K. Rajender Reddy,David R. Nelson,Christopher O’Brien,Yi Xu,Brian Murphy.Journal of Hepatology . 2007 (1)
[7]
Development of a heterologous, multigenotype vaccine against hepatitis C virus infection[J] . J.Encke,W.Radunz,C.Eisenbach,J.Geib,S.Gehrke,E.Pfaff,W.Stremmel.European Journal of Clinical Investigation . 2007 (5)
[8]
A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients[J] . Vincent G. Bain,Kelly D. Kaita,Eric M. Yoshida,Mark G. Swain,E. Jenny Heathcote,Avidan U. Neumann,Michele Fiscella,Ren Yu,Blaire L. Osborn,Patrick W. Cronin,William W. Freimuth,John G. McHutchison,G. Mani Subramanian.Journal of Hepatology . 2006 (4)
[9]
Successful Long-term Application of Highly Purified Natural Interferon-alpha （Multiferon?） after Preceding Interferon Approaches in a Chronic Hepatitis C Patient with Thrombocytopenia[J] . Eugen Musch,Mouhamad Malek,Harald von Eick,Angeliki Chrissafidou.Scandinavian Journal of Infectious Diseases . 2004 (5)
[10]
R-1626 a specific oral NS5Bpolymerase inhibitor of hepatitis C virus. Toniutto P,Fabris C,Bitetto D et al. IDrugs The Investigational Drugs Journal . 2008